Lifevantage Corp. said its normalized net income for the fiscal second quarter ended Dec. 31, 2014, amounted to 9 cents per share, compared with the S&P Capital IQ consensus estimate of 21 cents per share.
EPS declined 52.1% year over year from 19 cents.
Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was $1.3 million, a decrease of 57.1% from $3.0 million in the prior-year period.
The normalized profit margin declined to 2.7% from 5.8% in the year-earlier period.
Total revenue decreased 6.4% year over year to $48.2 million from $51.5 million, and total operating expenses fell from the prior-year period to $45.2 million from $46.4 million.
Reported net income decreased 70.1% on an annual basis to $1.0 million, or 7 cents per share, from $3.4 million, or 21 cents per share.
